期刊文献+

Highly expressed Nl-acetylpolyamine oxidase detoxifies polyamine analogue N^1-cyclopropylmethyl-N^11-ethylnorspermine in human lung cancer cell line A549 被引量:2

Highly expressed Nl-acetylpolyamine oxidase detoxifies polyamine analogue N^1-cyclopropylmethyl-N^11-ethylnorspermine in human lung cancer cell line A549
原文传递
导出
摘要 Background The critical roles of polyamines in cell growth and differentiation have made polyamJne metabolic pathway a promising target for antitumor therapy. Recent studies have demonstrated in vitro that some antitumor polyamine analogues could be used as substrates and oxidized by purified recombinant human N^1-acetylpolyamine oxidase (APAO, an enzyme that catabolizes natural poiyamines), indicating a potential role of APAO in determining the sensitivity of cancer cells to specific antitumor analogues. This study evaluated, in vivo, the effect of APAO on cytotoxicity of antitumor polyamine analogue, N^1-cyclopropylmethyl-N^11-ethylnorspermine (CPENS) and its mechanism when highly expressed in human lung cancer line A549. Methods A clone with high expression of APAO was obtained by transfecting A549 lung cancer ceil line with pcDNA3.1/APAO plasmid and selecting with quantitative realtime PCR and APAO activity assay. Cell proliferation was determined by MTT method and apoptosis related events were evaluated by DNA fragmentation, sub-G1/flow cytometric assay, western blotting (for cytochrome C and Bax) and colorimetric assay (for casapse-3 activity). Results A clone highly expressing APAO was obtained. High expression of APAO in A549 cells inhibited accumulation of CPENS, decreased their sensitivity to the toxicity of CPENS and prevented CPENS induced apoptosis. Conclusion These results indicate a new drug resisting, mechanism in the tumor cells. High expression of APAO can greatly decrease the sensitivity of tumor cells to the specific polyamine analogues by detoxifying those analogues and prevent analogue induced apoptosis. Background The critical roles of polyamines in cell growth and differentiation have made polyamJne metabolic pathway a promising target for antitumor therapy. Recent studies have demonstrated in vitro that some antitumor polyamine analogues could be used as substrates and oxidized by purified recombinant human N^1-acetylpolyamine oxidase (APAO, an enzyme that catabolizes natural poiyamines), indicating a potential role of APAO in determining the sensitivity of cancer cells to specific antitumor analogues. This study evaluated, in vivo, the effect of APAO on cytotoxicity of antitumor polyamine analogue, N^1-cyclopropylmethyl-N^11-ethylnorspermine (CPENS) and its mechanism when highly expressed in human lung cancer line A549. Methods A clone with high expression of APAO was obtained by transfecting A549 lung cancer ceil line with pcDNA3.1/APAO plasmid and selecting with quantitative realtime PCR and APAO activity assay. Cell proliferation was determined by MTT method and apoptosis related events were evaluated by DNA fragmentation, sub-G1/flow cytometric assay, western blotting (for cytochrome C and Bax) and colorimetric assay (for casapse-3 activity). Results A clone highly expressing APAO was obtained. High expression of APAO in A549 cells inhibited accumulation of CPENS, decreased their sensitivity to the toxicity of CPENS and prevented CPENS induced apoptosis. Conclusion These results indicate a new drug resisting, mechanism in the tumor cells. High expression of APAO can greatly decrease the sensitivity of tumor cells to the specific polyamine analogues by detoxifying those analogues and prevent analogue induced apoptosis.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第12期1394-1399,共6页 中华医学杂志(英文版)
基金 This work was supported by grants from the National Natural Science Foundation of China (No. 30772590) and Natural Science Foundation of Hubei Department of Education (No. D200713003).
关键词 N^1-acetylpolyamine oxidase lung cancer cell polyamine analogue drug resistance N^1-acetylpolyamine oxidase lung cancer cell polyamine analogue drug resistance
  • 相关文献

参考文献18

  • 1Casero RA, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases.Nature Reviews/Drug Discovery 2007; 6: 373-390.
  • 2Gemer EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Nature Reviews/Cancer 2004; 4:781-792.
  • 3Bachrach U. Polyamine and cancer. Amino Acids 2004; 26: 307-309.
  • 4Moibard C, Cynober L, de Bandt JE Polyamine metabolism and implications in human diseases. Clinic Nutrition 2005; 24: 184-179.
  • 5Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003; 376: 1-14.
  • 6Wang Y, Casero RA. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem 2006; 139: 17-25.
  • 7Casero RA, Wang Y, Murray-Steward T, Devereux W, Hacker A, Wang YC, et al. The role of polyamine catabolism in antitumor drug response. Biochemical Society Transactions 2003; 31 (part 2): 361-365.
  • 8Zhao YC, Chi Y J, Yu YS, Liu JL, Su RW, Ma XH, et al. Polyamines are essential in embryo implantation: expression and function of polyamine related genes in mouse uterus peri-implantation period. Endocrinology 2008; 149: 2325-2332.
  • 9Yanlin W, Devereux W, Woster PM, Murray-Steward T, Hacker A, Casero RA. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 2001; 61: 5370-5373.
  • 10Devereux W, Wang Y, Murray-Steward T, Hacker A, Smith R, Frydman B, et al. Induction of PAOhl/SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother Pharmacol 2003; 52: 383-390.

同被引文献1

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部